Verisk Analytics said revenues for the 3 months ended September 30, 2025 were $768.3 million, an increase of $43.0 million or 5.9% from $725.3 million in the prior-year period. Underwriting revenue increased 6.9% and claims revenue increased 3.6%.

1. 01

   Verisk Analytics said revenues for the 3 months ended September 30, 2025 were $768.3 million, an increase of $43.0 million or 5.9% from $725.3 million in the prior-year period. Underwriting revenue increased 6.9% and claims revenue increased 3.6%.

2. 02

   The company said net income for the 9 months decreased 4.8% to $711.1 million from $747.2 million in the prior-year period, and EBITDA margin was 56.2% compared to 59.3% in the prior year. It cited net gains realized in the prior year from the settlement of retained interests related to prior sales of its healthcare business and specialized markets business, and a net gain on early extinguishment of debt in the prior year, as factors in the margin decline.

3. 03

   Verisk Analytics said that as of September 30, 2025, cash and cash equivalents and available-for-sale securities totaled $2,108.7 million, compared to $292.5 million as of December 31, 2024, and total debt, excluding finance lease liabilities, unamortized discounts and debt issuance costs, was $4,750 million compared to $3,050.0 million.

4. 04

   On August 15, 2025, the company increased its Syndicated Revolving Credit Facility borrowing capacity to $1,250.0 million and extended the maturity date to August 15, 2030, and entered into a Term Loan Facility of $750.0 million. Verisk Analytics said it plans to use the borrowings for the acquisition of AccuLynx and related costs.

Key figures

Quarter ended September 30, 2025

Revenue

$768M

Operating income

$346M

Net income

$226M

EPS

$1.61

Operating cash flow

$404M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.